Skip to main content
See every side of every news story
Published loading...Updated

Why Iovance Biotherapeutics Stock Plummeted Today @themotleyfool #stocks $IOVA

Summary by The Motley Fool
Key PointsInvestors were hardly pleased by the company's double miss on second-quarter results.At least its revenue guidance was in line with expectations.10 stocks we like better than Iovance Biotherapeutics › Investors are typically quite harsh on publicly traded companies that don't make their quarterly estimates, a dynamic vividly on display Friday with biotech stock Iovance Biotherapeutics (NASDAQ: IOVA). The company published its second-qu…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Friday, August 8, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal